|
Q4 2021
Filed on Feb 10, 2022
|
30,000
|
$12.96 - $16.56
$389K - $497K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
6,891
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
10,000
|
$15.04 - $24.27
$150K - $243K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
22,088
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
24,754
|
$1.27 - $2.42
$31.4K - $59.9K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
19,143
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
304,876
|
$4.5 - $10.7
$1.37M - $3.26M
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
67,736
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
10,702
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
20,031
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
8,098
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
15,000
|
$9.39 - $16.29
$141K - $244K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
180,000
|
$6.19 - $8.36
$1.11M - $1.5M
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
75,000
|
$8.49 - $16.7
$637K - $1.25M
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
300,000
|
$15.99 - $18.69
$4.8M - $5.61M
|
|
Dicerna Pharmaceuticals Inc
|
Q4 2021
Filed on Feb 10, 2022
|
10,871
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
904,950
|
$65.63 - $91.55
$59.4M - $82.8M
|
|
Enable Midstream Partners LP
|
Q4 2021
Filed on Feb 10, 2022
|
17,015
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
20,000
|
$14.15 - $34.24
$283K - $685K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
2,609
|
$11.35 - $97.17
$29.6K - $254K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
1,094,343
|
$16.89 - $27.15
$18.5M - $29.7M
|
|
Bancorpsouth Bk Tupelo Miss
|
Q4 2021
Filed on Feb 10, 2022
|
16,057
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
20,000
|
$8.92 - $15.66
$178K - $313K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
3,842
|
$45.28 - $74.5
$174K - $286K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
6,539
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
14,557
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
15,000
|
$17.49 - $26.72
$262K - $401K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
50,000
|
$10.4 - $13.53
$520K - $677K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
5,053
|
$54.02 - $63.83
$273K - $323K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
6,619
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
54,702
|
$17.71 - $29.6
$969K - $1.62M
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
100,000
|
$3.37 - $10.5
$337K - $1.05M
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
12,411
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
8,606
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
15,768
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
15,612
|
N/A
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
5,187
|
$21.96 - $42.69
$114K - $221K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
6,100
|
$252.3 - $354.44
$1.54M - $2.16M
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
2,284
|
$60.67 - $99.5
$139K - $227K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
23,577
|
$1.79 - $2.82
$42.2K - $66.5K
|
|
|
Q4 2021
Filed on Feb 10, 2022
|
25,000
|
$29.09 - $51.45
$727K - $1.29M
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
24,744
|
$4.1 - $5.42
$101K - $134K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
58,504
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
484,791
|
$50.02 - $76.42
$24.2M - $37M
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
5,944
|
N/A
|
|
Alexion Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 09, 2021
|
28,730
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
30,746
|
$17.89 - $27.53
$550K - $846K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
14,299
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
39,815
|
$64.33 - $121.11
$2.56M - $4.82M
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
7,410
|
N/A
|
|